Buy Stocks Easy | About Us
January 26, 2022
Buy Stocks Easy | Online Stocks

ADVM


Buy Adverum Biotechnologies, Inc. Stock (symbol: ADVM) Easy Online

Company Name: Adverum Biotechnologies, Inc.

Symbol: ADVM

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

IPO: 2016

ADVM Current Share Price

Today's ADVM ( Adverum Biotechnologies, Inc. ) opening price: $11.0300

Yesterday's ADVM ( Adverum Biotechnologies, Inc. ) closing price: $10.9500

Adverum Biotechnologies, Inc. Stock ( symbol: ADVM ) Price Chart since IPO (2016):

12 Months Adverum Biotechnologies, Inc. Stock ( symbol: ADVM ) Price Chart

Popular Questions about Adverum Biotechnologies, Inc. Public Stock ( ADVM )

A: Adverum Biotechnologies, Inc. stock symbol (also called stock or share ticker) is ADVM

A: Adverum Biotechnologies, Inc. IPO (Initial Public Offering) took place on 2016

A: Adverum Biotechnologies, Inc.'s stock (ADVM symbol) price at ther IPO (initial Public Offering) was $11.0300

Q: Is ADVM stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Adverum Biotechnologies, Inc. stock (symbol: ADVM) at the beginning of 2019, at the opening share price of $3.1800, with a minimum of $200, by now your shares would be worth $12778 and your profit would be $12578 - SHOW ONLY IF PROFIT.

Buy Adverum Biotechnologies, Inc. Stock Easy Online

Adverum Biotechnologies, Inc. Stock Ticker Price Chart since IPO:





Adverum Biotechnologies, Inc. Stock Price Yesterday



 


Adverum Biotechnologies, Inc. Stock Price – Last Week




 


Adverum Biotechnologies, Inc. Stock Price – Last Month




 


Adverum Biotechnologies, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            https://seekingalpha.com/article/4305094-adverum-biotechnologies-inc-advm-ceo-leone-patterson-q3-2019-results-earnings-call-transcript
                            

                                
Adverum Biotechnologies, Inc. (ADVM) CEO Leone Patterson on Q3 2019 Results - Earnings Call Transcript

                                
                                
Adverum Biotechnologies, Inc. (ADVM) CEO Leone Patterson on Q3 2019...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/609198/adverum-biotechnologies-advm-reports-q3-loss-misses-revenue-estimates
                            

                                
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Misses Revenue Estimates

                                
                                
Adverum Biotechnologies (ADVM) delivered earnings and revenue surpr...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/30/1938250/0/en/Adverum-Biotechnologies-Expands-Leadership-Team-with-the-Appointment-of-Peter-Soparkar-as-Chief-Legal-Officer.html
                            

                                
Adverum Biotechnologies Expands Leadership Team with the Appointment of Peter Soparkar as Chief Legal Officer

                                
                                
MENLO PARK, Calif., Oct.  30, 2019  (GLOBE NEWSWIRE) -- Adverum Bio...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/24/1934905/0/en/Adverum-Biotechnologies-Doses-First-Patient-in-Third-Cohort-of-OPTIC-Phase-1-Clinical-Trial-of-ADVM-022-Intravitreal-Gene-Therapy-for-Wet-AMD.html
                            

                                
Adverum Biotechnologies Doses First Patient in Third Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD

                                
                                
Patients in the Third Cohort of OPTIC will Receive a Single ADVM-02...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/23/1934062/0/en/Adverum-Biotechnologies-Announces-Data-Presentations-at-the-European-Society-of-Gene-and-Cell-Therapy-ESGCT-2019-Congress.html
                            

                                
Adverum Biotechnologies Announces Data Presentations at the European Society of Gene and Cell Therapy (ESGCT) 2019 Congress

                                
                                
-- Szilárd Kiss, M.D. to present an encore presentation of data fro...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/11/1928842/0/en/Adverum-Biotechnologies-Reports-Additional-Clinical-Data-from-First-Cohort-of-OPTIC-Phase-1-Trial-of-ADVM-022-Intravitreal-Gene-Therapy-for-Wet-AMD-at-the-American-Academy-of-Ophth.html
                            

                                
Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting

                                
                                
-- Zero anti-VEGF rescue injections required in the first cohort an...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/542588/adverum-biotechnologies-enters-oversold-territory
                            

                                
Adverum Biotechnologies Enters Oversold Territory

                                
                                
Adverum Biotechnologies has been on a bit of a cold streak lately, ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/26/1921617/0/en/Adverum-Biotechnologies-to-Present-Additional-Clinical-Data-from-First-Cohort-of-OPTIC-Phase-1-Trial-of-ADVM-022-Intravitreal-Gene-Therapy-to-Treat-Wet-AMD-at-the-American-Academy-.html
                            

                                
Adverum Biotechnologies to Present Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy to Treat Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting

                                
                                
Company to Host and Webcast a Discussion with Key Opinion Leaders o...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305094-adverum-biotechnologies-inc-advm-ceo-leone-patterson-q3-2019-results-earnings-call-transcript
                            

                                
Adverum Biotechnologies, Inc. (ADVM) CEO Leone Patterson on Q3 2019 Results - Earnings Call Transcript

                                
                                
Adverum Biotechnologies, Inc. (ADVM) CEO Leone Patterson on Q3 2019...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/609198/adverum-biotechnologies-advm-reports-q3-loss-misses-revenue-estimates
                            

                                
Adverum Biotechnologies (ADVM) Reports Q3 Loss, Misses Revenue Estimates

                                
                                
Adverum Biotechnologies (ADVM) delivered earnings and revenue surpr...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/30/1938250/0/en/Adverum-Biotechnologies-Expands-Leadership-Team-with-the-Appointment-of-Peter-Soparkar-as-Chief-Legal-Officer.html
                            

                                
Adverum Biotechnologies Expands Leadership Team with the Appointment of Peter Soparkar as Chief Legal Officer

                                
                                
MENLO PARK, Calif., Oct.  30, 2019  (GLOBE NEWSWIRE) -- Adverum Bio...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/24/1934905/0/en/Adverum-Biotechnologies-Doses-First-Patient-in-Third-Cohort-of-OPTIC-Phase-1-Clinical-Trial-of-ADVM-022-Intravitreal-Gene-Therapy-for-Wet-AMD.html
                            

                                
Adverum Biotechnologies Doses First Patient in Third Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD

                                
                                
Patients in the Third Cohort of OPTIC will Receive a Single ADVM-02...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/23/1934062/0/en/Adverum-Biotechnologies-Announces-Data-Presentations-at-the-European-Society-of-Gene-and-Cell-Therapy-ESGCT-2019-Congress.html
                            

                                
Adverum Biotechnologies Announces Data Presentations at the European Society of Gene and Cell Therapy (ESGCT) 2019 Congress

                                
                                
-- Szilárd Kiss, M.D. to present an encore presentation of data fro...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/11/1928842/0/en/Adverum-Biotechnologies-Reports-Additional-Clinical-Data-from-First-Cohort-of-OPTIC-Phase-1-Trial-of-ADVM-022-Intravitreal-Gene-Therapy-for-Wet-AMD-at-the-American-Academy-of-Ophth.html
                            

                                
Adverum Biotechnologies Reports Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy for Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting

                                
                                
-- Zero anti-VEGF rescue injections required in the first cohort an...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/542588/adverum-biotechnologies-enters-oversold-territory
                            

                                
Adverum Biotechnologies Enters Oversold Territory

                                
                                
Adverum Biotechnologies has been on a bit of a cold streak lately, ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/26/1921617/0/en/Adverum-Biotechnologies-to-Present-Additional-Clinical-Data-from-First-Cohort-of-OPTIC-Phase-1-Trial-of-ADVM-022-Intravitreal-Gene-Therapy-to-Treat-Wet-AMD-at-the-American-Academy-.html
                            

                                
Adverum Biotechnologies to Present Additional Clinical Data from First Cohort of OPTIC Phase 1 Trial of ADVM-022 Intravitreal Gene Therapy to Treat Wet AMD at the American Academy of Ophthalmology 2019 Annual Meeting

                                
                                
Company to Host and Webcast a Discussion with Key Opinion Leaders o...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.